Zimmer Biomet Holdings, Inc. (ZBH)
What changed in recent filings
- Institutions — 4 new · 4 added · 1 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Zimmer Biomet Holdings, Inc. recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Aug 5, 2026Revenue +4.8% YoY · EPS $1.03Released before the open: Aug 4 close → Aug 5 close, the stock moved +2.5% · over the same window, market -0.2% · sector +0.5%
- 26Q1Released Apr 28, 2026Revenue +9.3% YoY · EPS $1.22Released before the open: Apr 27 close → Apr 28 close, the stock moved -10.6% · over the same window, market -0.5% · sector -0.5%
- 25Q4Released Feb 10, 2026Revenue +10.9% YoY · EPS $0.71Released before the open: Feb 9 close → Feb 10 close, the stock moved +1.9% · over the same window, market -0.3% · sector -0.3%
- 25Q3Released Nov 5, 2025Revenue +9.7% YoY · EPS $1.16Released before the open: Nov 4 close → Nov 5 close, the stock moved -15.1% · over the same window, market +0.3% · sector +0.2%
The next earnings release is estimated around Nov 4, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Institutions holding Zimmer Biomet Holdings, Inc.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 6 → 2026 Q2: 10 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Zimmer Biomet Holdings, Inc.
Institutions we track that reported holding this stock in their most recent 13F.
- National Pension Service (Korea)0.01% of portfolio · held as of 2019 Q1 or earlier
- PRIMECAP Management0.19% of portfolio · held as of 2019 Q1 or earlier
- Bridgewater Associates0.01% of portfolio · since 2020 Q3
- Dodge & Cox1.09% of portfolio · since 2022 Q1
- Harris Associates (Oakmark)1.45% of portfolio · since 2025 Q2
- Capital World Investorsunder 0.01% of portfolio · since 2025 Q2
- Tudor Investment CorpNew this quarter0.01% of portfolio · since 2026 Q2
- Point72 Asset ManagementNew this quarter0.08% of portfolio · since 2026 Q2
- Moore Capital ManagementNew this quarter0.25% of portfolio · since 2026 Q2
- BlackstoneNew this quarterunder 0.01% of portfolio · since 2026 Q2
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
Zimmer Biomet Holdings Inc. is a global medical technology company focused on musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip systems, along with sports medicine, biologics, extremities, and trauma solutions. Its portfolio also includes craniomaxillofacial and thoracic products, office-based technologies, bone cement, surgical instruments, and integrated digital and robotic technologies used in orthopedic procedures. Zimmer Biomet serves healthcare professionals, hospitals, and surgical centers by providing products that support the treatment of bone, joint, and soft-tissue disorders. Headquartered in Warsaw, Indiana, Zimmer Biomet plays an important role in orthopedic care across major markets worldwide.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Zimmer Biomet Holdings, Inc. is classified under the Biotech & Health sector. See peers below.
Zimmer Biomet Holdings, Inc. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
Zimmer Biomet Holdings, Inc. vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding Zimmer Biomet Holdings, Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
ZBH on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
ZBH FAQ
What is Zimmer Biomet Holdings, Inc. (ZBH)?
Zimmer Biomet Holdings Inc. is a global medical technology company focused on musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip systems, along with sports medicine, biologics, extremities, and trauma solutions. Its portfolio also includes craniomaxillofacial and thoracic products, office-based technologies, bone cement, surgical instruments, and integrated digital and robotic technologies used in orthopedic procedures. Zimmer Biomet serves healthcare professionals, hospitals, and surgical centers by providing products that support the treatment of bone, joint, and soft-tissue disorders. Headquartered in Warsaw, Indiana, Zimmer Biomet plays an important role in orthopedic care across major markets worldwide.
What sector is Zimmer Biomet Holdings, Inc. in?
Zimmer Biomet Holdings, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Zimmer Biomet Holdings, Inc.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 8.6%, Operating margin 15.0%, Net margin 9.5%, ROE 5.6%, Debt-to-equity 0.50x. Definitions and interpretation are available on Stocklore.
Where can I analyze Zimmer Biomet Holdings, Inc. (ZBH) stock?
On Stocklore you can see ZBH's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.